Risk of developing CMV retinitis following non-ocular CMV end organ disease in AIDS patients

British Journal of Ophthalmology

Volumn 82, Issue 7, 1998, Pages 748-750

  Verbraak, Frank D ^a   Van Den Horn, Gerardus J ^a   Van Der Meer, Jan T M ^a   Paydafar, Darius ^a   Ten Kate, Fibo J W ^a   Wertheim van Dillen, Pauline M E ^a   Kijlstra, Aize ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FOSCARNET SODIUM; GANCICLOVIR; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DISEASE PREDISPOSITION; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; MEDICAL RECORD; PRIORITY JOURNAL; RETINITIS; RISK ASSESSMENT; SURVIVAL TIME; TIME;

EID: 0031845133     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.7.748     Document Type: Article

References (14)

1. Gallant JL, Moore RD, Richman DD, et al. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992;166:1223-7.
2. Spector SA, McKinley GF, Lalezar JP, et al. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. N Engl J Med 1996;334:1491-7.
3. Hoover DR, Peng Y, Saah A, et al. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppresion. Arch Ophthalmol 1996;114:821-7.
4. Chui Dw, Owen RL. AIDS and the gut. J Gastroenterol Hepatol 1994;9:291-303.
5. Sutton FM, Graham DY, Goodgame RW. Infectious esophagitis. Gastrointest Endosc Clin NA 1994;4:713-29.
6. Blanshard C, Benhamon Y, Dohin E, et al. Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison. J Infect Dis 1995;172:622-8.
7. Danner SA. Management of cytomegalovirus disease. AIDS 195;9(Suppl 2):S3-8.
8. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Suppl 1987;36:1S-3S.
9. Salomon N, Gomez T, Perlman DC, et al. Clinical features and outcome of HIV-related cytomegalovirus pneumonia. AIDS 1997;11:319-24.
10. van der Meer JTM, Drew WL, Bowden RA, et al. Summary of the international consensus symposium on advances on the diagnosis, treatment and prophylaxis of cytomegalovirus infection. Antiviral Res 1996;32:119-40.
11. Mentec O, Leport C, Leport J, et al. Cytomegalovirus colitis in HIV-1-infected patients: a prospective research in 55 patients. AIDS 1994;8:461-7.
12. Dieterich DT, Kotler DP, Busch DF, et al. Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized double-blind, placebo-controlled multicenter study. J Infect Dis 1993;167:278-82.
13. Dieterich DT, Rahmin M. Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature. J Acquir Imm Def Syndrome 1991;4(Suppl):S29-35.
14. d'Arminio Montforte A, Mainini F, et al. Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS. AIDS 1997;11:517-24.